Abstract
During the last few years increasing experimental evidence has accumulated which indicates that PAF-acether (AGEPC, 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) is a potential mediator of inflammation and anaphylaxis (1,2). In chapter 6 of this book Page and co-workers give evidence that PAF-acether fulfils most of the criteria appropriate for an inflammatory mediator. Among these criteria, however, there are two points that await further support by experimental data. Firstly, the generation of PAF-acether during inflammation has been only scantily documented. Secondly, there is no evidence that the inhibition of the release or the actions of PAF-acether leads to an anti-inflammatory effect.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Vargaftig, B.B., Chignard, M., Benveniste, J., Le Fort, J. and Wal, F. (1981). Background and present status of research on platelet-activating factor (PAF-acether). Ann. N.Y. Acad. Sci., 370, 119–137.
Pinckard, R.N., McManus, L.M. and Hanahan, D.J. (1982). Chemistry and biology of acetyl glyceryl ether phosphorylcholine (platelet activating factor). In Advances in Inflammation Research, (ed. G. Weissman). Raven Press, New York, pp. 147–180.
Mencia-Huerta, J-M., Roubin, R., Morgat, J-L. and Benveniste, J. (1982). Biosynthesis of platelet-activating factor (PAF-acether). III. Formation of PAF-acether from synthetic substrates by stimulated murine macrophages. J. Immunol., 129, 804–808.
Albert, D.H. and Snyder, F. (1983). Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) from 1-alkyl-2-acyl-sn-glycero-3 phosphocholine by rat alveolar macrophages. Phospholipase A2 and acetyltransferase activities during phagocytosis and ionophore stimulation. J. Biol. Chem., 258, 97–102.
Parente, L. and Flower, R.J. (1985). Hydrocortisone and “macrocortin” inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes. Life Sci., 36, 1225–1231.
Blank, M.L., Lee, T-C, Fitzgerald, V. and Snyder, F. (1981). A specific acetyl-hydrolase for l-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J. Biol. Chem., 256, 175–178.
Parente, L., Koh, M.S., Willoughby, D.A. and Kitchen, A. (1979). Studies on cell motility in inflammation. I. The chemotactic activity of experimental inflammatory exudates. Agents Actions, 9, 190–195.
Parente, L. and Flower, R.J. (1985). Manuscript in preparation.
Blackwell, G.J., Carnuccio, R., Di Rosa, M., Flower, R.J., Langham, C.S.J., Parente, L., Persico, P., Russell-Smith, N.C. and Stone, D. (1982). Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. Br. J. Pharmac, 76, 185–194.
Editor information
Editors and Affiliations
Copyright information
© 1985 The Contributors
About this chapter
Cite this chapter
Parente, L., Flower, R.J. (1985). The Generation of Lyso-PAF in Experimental Inflammation. In: Higgs, G.A., Williams, T.J. (eds) Inflammatory Mediators. Satellite Symposia of the IUPHAR 9th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-07834-9_7
Download citation
DOI: https://doi.org/10.1007/978-1-349-07834-9_7
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-07836-3
Online ISBN: 978-1-349-07834-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)